Herreros Jesus, Bustamante Juan
Department of Cardiovascular Surgery, Valdecilla University Hospital, Santander, Spain.
Expert Rev Cardiovasc Ther. 2011 Aug;9(8):1027-39. doi: 10.1586/erc.11.114.
Heart failure currently constitutes one of the greatest health problems in the Western world. Its incidence, far from diminishing or even remaining stable, is actually still increasing in association with the aging of the population and its lifestyle. A better knowledge of physiopathological mechanisms has allowed for the development of new therapeutic focal points and lines of research. Nevertheless, its treatment is complex and encompasses a multidisciplinary approach. Patients in an advanced stage still have a very high mortality rate in spite of receiving optimum medical care. The development of new therapeutic techniques that afford a better prognosis has therefore been essential. Of these, and leaving aside surgical treatments, myocardial regeneration by means of cellular therapy, new concepts in tissue engineering and their results, and the applications of new advances in the field of immunomodulation have all recently experienced development. In this article, the aim is to bring the latest concepts in the physiopathology and humoral response of cardiac failure up to date as well as doing the same with the therapeutic approaches in this area.
心力衰竭目前是西方世界最严重的健康问题之一。其发病率不但没有下降甚至保持稳定,实际上还随着人口老龄化及其生活方式的改变而不断上升。对生理病理机制的深入了解催生了新的治疗重点和研究方向。然而,其治疗过程复杂,需要多学科方法。尽管接受了最佳医疗护理,晚期患者的死亡率仍然很高。因此,开发具有更好预后的新治疗技术至关重要。其中,除了外科治疗外,通过细胞疗法进行心肌再生、组织工程的新概念及其成果,以及免疫调节领域新进展的应用,最近都有了发展。本文旨在介绍心力衰竭生理病理学和体液反应的最新概念,以及该领域的治疗方法。